Taylor & Francis · United States
Human Vaccines & Immunotherapeutics
ISSN 2164-5515, 2164-554X
Open accessListed in DOAJMedicineLife sciencesSocial sciences
Article charge A$5,085 or €3,505 or £2,920 or US$3,650 · waivers offered · licence CC BY, CC BY-NC · about 11 weeks to publication (DOAJ)
Figures
- Works
- 7.2k
- Citations
- 152.8k
- h-index
- 130
- 2-year mean citedness
- 4.42
Source: OpenAlex (CC0), read 9 Oct 2026. Counts of the works OpenAlex indexes, not a ranking.
Topics it publishes most
- Vaccine Coverage and Hesitancy
- Bacterial Infections and Vaccines
- SARS-CoV-2 and COVID-19 Research
- Immunotherapy and Immune Responses
- Cervical Cancer and HPV Research
- Intramuscular injections and effects
- Immune responses and vaccinations
- Influenza Virus Research Studies
Open calls on pitute (11)
Calls for papers, special issues and article collections of this journal that pitute holds open today.
- Article collection: Human Vaccines & Immunotherapeutics: CAR T Cell Therapies Beyond OncologyCloses 15 Oct 2026
- Article collection: Human Vaccines & Immunotherapeutics: Vaccines at a Crossroads: Precision Vaccinology as a New ParadigmCloses 16 Oct 2026
- Article collection: Human Vaccines & Immunotherapeutics: Deciphering Immunotherapy Resistance: Targets, Mechanisms, and Therapeutic InnovationsCloses 16 Nov 2026
- Article collection: Human Vaccines & Immunotherapeutics: Human Microbiome and Vaccine EfficacyCloses 30 Nov 2026
- Article collection: Human Vaccines & Immunotherapeutics: Immunization and DisastersCloses 1 Dec 2026
- Article collection: Advances and Implementation Challenges in Vaccine Confidence, Access, and Immunization Programs in LMICs of the Global SouthCloses 31 Dec 2026
- Article collection: Human Vaccines & Immunotherapeutics: Advancing Immunization in China: Bridging Policy, Evidence, and PracticeCloses 1 Feb 2027
